These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 28187430)
1. Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies. Huang QT; Man QQ; Hu J; Yang YL; Zhang YM; Wang W; Zhong M; Yu YH Oncotarget; 2017 Mar; 8(10):16755-16764. PubMed ID: 28187430 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Huang QT; Zhou L; Zeng WJ; Ma QQ; Wang W; Zhong M; Yu YH Cell Physiol Biochem; 2017; 41(6):2411-2418. PubMed ID: 28467978 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review. Wu J; Chen M; Liang C; Su W Oncotarget; 2017 Feb; 8(8):13400-13412. PubMed ID: 28077792 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies. Han X; Liu S; Yang G; Hosseinifard H; Imani S; Yang L; Maghsoudloo M; Fu S; Wen Q; Liu Q Gynecol Oncol; 2021 Jan; 160(1):351-360. PubMed ID: 33092868 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer. Onal C; Guler OC; Yildirim BA Int J Gynecol Cancer; 2016 Jul; 26(6):1169-75. PubMed ID: 27206286 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of neutrophil-to-lymphocyte ratio in patients with oral cancer. Yang Y; Liu R; Ren F; Guo R; Zhang P Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30446526 [No Abstract] [Full Text] [Related]
7. Neutrophil-to-lymphocyte ratio is an independent predictor for survival outcomes in cervical cancer: a systematic review and meta-analysis. Zou P; Yang E; Li Z Sci Rep; 2020 Dec; 10(1):21917. PubMed ID: 33318608 [TBL] [Abstract][Full Text] [Related]
8. Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis. Ethier JL; Desautels DN; Templeton AJ; Oza A; Amir E; Lheureux S Gynecol Oncol; 2017 Jun; 145(3):584-594. PubMed ID: 28222899 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in melanoma patients: A meta-analysis. Zhan H; Ma JY; Jian QC Clin Chim Acta; 2018 Sep; 484():136-140. PubMed ID: 29856976 [TBL] [Abstract][Full Text] [Related]
11. The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis. Min GT; Li YM; Yao N; Wang J; Wang HP; Chen W Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29112283 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer. Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis. Tang H; Li B; Zhang A; Lu W; Xiang C; Dong J PLoS One; 2016; 11(7):e0159447. PubMed ID: 27427969 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis. Tang L; Li X; Wang B; Luo G; Gu L; Chen L; Liu K; Gao Y; Zhang X PLoS One; 2016; 11(4):e0153981. PubMed ID: 27096158 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis. Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336 [TBL] [Abstract][Full Text] [Related]
16. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies. Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879 [TBL] [Abstract][Full Text] [Related]
17. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Li MX; Liu XM; Zhang XF; Zhang JF; Wang WL; Zhu Y; Dong J; Cheng JW; Liu ZW; Ma L; Lv Y Int J Cancer; 2014 May; 134(10):2403-13. PubMed ID: 24122750 [TBL] [Abstract][Full Text] [Related]
18. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery. Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis. Chen S; Zhang L; Yan G; Cheng S; Fathy AH; Yan N; Zhao Y Biomed Res Int; 2017; 2017():7943467. PubMed ID: 28815182 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors. Na N; Yao J; Cheng C; Huang Z; Hong L; Li H; Qiu J Oncotarget; 2016 Jul; 7(28):44039-44046. PubMed ID: 27270655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]